Gilead Sciences Ireland Unlimited Company
3 products tracked · names used in filings: Gilead Sciences Ireland Unlimited Company
Upcoming milestones
No upcoming milestones listed.
Recent milestones
No recent milestones.
Products
| Product | Status | Approved | |
|---|---|---|---|
| 🇪🇺 | Lyvdelzi (previously Seladelpar Gilead) seladelpar lysine dihydrate | Authorised | |
| 🇪🇺 | Yeytuo lenacapavir | Authorised | 2025-08-25 |
| 🇪🇺 | Sunlenca lenacapavir | Authorised | 2022-08-17 |
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.